Fixed ratio drug combination treatments for solid tumors

Details Fixed ratio drug combination treatments for solid tumors Fixed ratio drug combination treatments for solid tumors

2006-10-25

2010-11-30

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

Reexamination Certificate

active

07842676

ABSTRACT:
Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of irinotecan and floxuridine. Such methods are particularly useful in the treatment of cancer patients with advanced solid tumors.

REFERENCES:
patent: WO-03/028696 (2003-04-01), None
patent: WO-2004/087115 (2004-10-01), None
Reagan-Shaw, S., Nihal, M., Ahmad, N. (2007) Dose translation from animal to human studies revisited. The FASEB Journal, vol. 22, p. 659-661.
Rougier, P. and coworkers. (1998) Randomised trial of irinotecan versus fluorouracil by continuous infustion after fluorouracil failure in patients with metastatic colorectal cancer. The Lancet, vol. 352, p. 1407-1412.
Ansel, H.C., Allen, Jr., L.V., Popovich, N.G. (1999) Pharmaceutical Dosage Forms and Drug Delivery Systems. Published by Lippincott Williams & Wilkins, p. 23-26.
“Development & Approval Process (Drugs)” from the U.S. Food and Drug Administration [online], [retrieved Mar. 18, 2010]. Retrieved from the internet <http://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htm>, last updated Oct. 27, 2009.
“Clinical Cancer Advances 2006” published in the Journal of Clinical Oncology (2007), vol. 25, No. 1, p. 1-30.
Raphaël, R., Yves, D., Giselle, C., Magali, M., Odile, C.M. (May 2005) Cancer treatment at home or in the hospital: what are the costs for French public health insurance: Findings of a comprehensive-cancer centre. Health Policy, vol. 72, p. 141-148.
André, T., Louvet, C., Maindrault-Goebel, F., Couteau, C., Mabro, M., Lotz, J.P., Gilles-Amar, V., Krulik, M., Carola, E., Izrael, V., de Gramont, A. (1999) CPT-11 Addition to Bimonthly, High-dose Leucovorin and Bolus and Continuous-infusion 5-Fluorouracil for Pretreated Metastatic Colorectal Cancer. European J. of Cancer, vol. 35, p. 1343-1347.
“Practice Guidelines in Oncology—v.3.2010” on “Colon Cancer” by the National Comprehensive Cancer Network. Published May 28, 2010.
Allen et al., Science (Mar. 2004) 303:1818-1822.
Cao et al., Cancer Res (Jul. 2000) 60:3717-3721.
International Search Report for PCT/US2006/041832, date mailed on Apr. 24, 2007, 6 pages.
Litvak et al., Annals of Surgical Oncology (2002) 9(2):148-155.
Pitot et al., J. Clin. Oncol. (1997) 2910-2919.

Affiliated with

Also associated with

Rating

Fixed ratio drug combination treatments for solid tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fixed ratio drug combination treatments for solid tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fixed ratio drug combination treatments for solid tumors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4247888